HDAC inhibitors may offer new strategy for reversing fibrotic wall around pancreatic tumors
Pancreatic cancer is one of the deadliest cancers-;only about one in eight patients survives five years after diagnosis.
Source: news-medical.net
Stay updated with breaking news from Ester Banayo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pancreatic cancer is one of the deadliest cancers-;only about one in eight patients survives five years after diagnosis.
Salk scientists identified new set of molecules that drive the growth of human pancreatic cancer cell lines, explaining how genetic mutations can activate genetic "super-enhancers" that promote out-of-control pancreatic cancer growth. They show the efficacy of an experimental drug that targets a super-enhancer related protein, demonstrating the promise of therapeutics that block the effects of super-enhancers.